PRVB - Provention Bio - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

PRVB is currently covered by 7 analysts with an average price target of $6.01. This is a potential upside of $6.01 (0%) from yesterday's end of day stock price of $0.

Provention Bio's activity chart (see below) currently has 22 price targets and 31 ratings on display. The stock rating distribution of PRVB is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.08% with an average time for these price targets to be met of 230.09 days.

Highest price target for PRVB is $24, Lowest price target is $3, average price target is $6.01.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 15-Mar-2023. First documented stock forecast 18-Jan-2019.

Currently out of the existing stock ratings of PRVB, 12 are a BUY (75%), 4 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

25

$0.02 (0.08%)

16

1 years 1 months 10 days ago

3/7 (42.86%)

$1.09 (4.56%)

138

Hold

25

$0.02 (0.08%)

22

1 years 1 months 11 days ago

3/4 (75%)

$1.03 (4.30%)

124

Hold

25

$0.02 (0.08%)

30

1 years 1 months 11 days ago

0/2 (0%)

$1.03 (4.30%)

Buy

25

$0.02 (0.08%)

30

1 years 1 months 12 days ago

2/4 (50%)

$0.9 (3.73%)

175

Hold

16

$-8.98 (-35.95%)

12

1 years 1 months 12 days ago

1/2 (50%)

$-8.1 (-33.61%)

255

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRVB (Provention Bio) average time for price targets to be met?

On average it took 230.09 days on average for the stock forecasts to be realized with a an average price target met ratio 47.08

Which analyst has the current highest performing score on PRVB (Provention Bio) with a proven track record?

GEULAH LIVSHITS

Which analyst has the most public recommendations on PRVB (Provention Bio)?

Geulah Livshits works at CHARDAN CAPITAL and has 6 price targets and 9 ratings on PRVB

Which analyst is the currently most bullish on PRVB (Provention Bio)?

Pasha Sarraf with highest potential upside - $10.02

Which analyst is the currently most reserved on PRVB (Provention Bio)?

Gregory Renza with lowest potential downside - -$14.98

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?